GetTopicDetailResponse(id=53a0116898cf, topicName=CNS淋巴瘤, introduction=, content=伊布替尼 CNS淋巴瘤, image=null, comments=0, allHits=829, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Jul 21 00:50:09 CST 2024, time=2024-07-21, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=474242, tagList=[TagDto(tagId=474242, tagName=CNS淋巴瘤)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2269119, encodeId=7ee82269119e0, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=53a0116898cf' target=_blank style='color:#2F92EE;'>#CNS淋巴瘤#</a>, objectTitle=CAR-T治療100例原發(fā)或繼發(fā)CNS淋巴瘤的歐洲真實(shí)世界研究, objectType=article, longId=881996, objectId=486b88199680, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220803/1659517467560_8252897.webp, objectUrl=/article/show_article.do?id=486b88199680, replyNumber=0, likeNumber=23, createdTime=2025-06-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=486b88199680, moduleTitle=CAR-T治療100例原發(fā)或繼發(fā)CNS淋巴瘤的歐洲真實(shí)世界研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=486b88199680)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231980, encodeId=5c44223198067, content=<a href='/topic/show?id=53a0116898cf' target=_blank style='color:#2F92EE;'>#CNS淋巴瘤#</a> <a href='/topic/show?id=d03812035e99' target=_blank style='color:#2F92EE;'>#CD19/CD22#</a>, objectTitle=曹陽(yáng)/張義成教授牽頭，自體移植序貫CD19/CD22 CAR-T治療R/R CNS淋巴瘤療效顯著, objectType=article, longId=847721, objectId=129484e721aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401015/1728978299722_8538692.jpg, objectUrl=/article/show_article.do?id=129484e721aa, replyNumber=0, likeNumber=53, createdTime=2024-10-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=129484e721aa, moduleTitle=曹陽(yáng)/張義成教授牽頭，自體移植序貫CD19/CD22 CAR-T治療R/R CNS淋巴瘤療效顯著, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=129484e721aa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215994, encodeId=963d2215994eb, content=<a href='/topic/show?id=11fd2565952' target=_blank style='color:#2F92EE;'>#伊布替尼#</a> <a href='/topic/show?id=53a0116898cf' target=_blank style='color:#2F92EE;'>#CNS淋巴瘤#</a>, objectTitle=【CCR】伊布替尼單藥治療復(fù)發(fā)或難治性CNS淋巴瘤的II期研究結(jié)果, objectType=article, longId=835427, objectId=3cdf83542ee1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721284524390_8538692.jpg, objectUrl=/article/show_article.do?id=3cdf83542ee1, replyNumber=0, likeNumber=159, createdTime=2024-07-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3cdf83542ee1, moduleTitle=【CCR】伊布替尼單藥治療復(fù)發(fā)或難治性CNS淋巴瘤的II期研究結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3cdf83542ee1)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-07-21發(fā)表于上海
